Ovarian Cancer Trial, Recruiting NCT07242131 Sponsor: Ege University Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07242131
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 40 years of age.
  • People diagnosed with polycystic ovary syndrome (PCOS) based on specific medical criteria, meaning at least two of the following are present: irregular or absent periods, higher-than-normal levels of male hormones (or signs of this, such as excess hair growth), or ovaries that appear polycystic on an ultrasound.
  • People who do not have other serious ongoing health conditions alongside PCOS.
  • People who are willing to take part and are able to sign a written consent form agreeing to join the study.
  • People who are able to attend regular check-up appointments for at least 6 months.

Who may not be able to join:

  • People with known liver, kidney, heart, or hormonal conditions other than PCOS.
  • People who are currently pregnant or have used hormone-based treatments within the past 3 months.
  • People with a history of blood clots, breast cancer, or other health conditions that would make hormonal treatment unsafe.
  • People who would be unable to attend follow-up appointments or stick to the treatment plan as required.
  • People with significant difficulties with thinking or communication that would prevent them from giving proper consent or taking part in data collection.
  • People with a known allergy or sensitivity to any ingredient in the study medications.
  • People who have taken part in another clinical trial within the past 3 months.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905547139994

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ege University
Registry
ClinicalTrials.gov
Start date
1 December 2025
Est. completion
1 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Restoration of Regular Menstrual Cycles

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov